It was reported that a low baseline proportion of peripheral blood CD4+ Tregs was associated with subsequent colitis caused by ipilimumab (13), consistent with previous views that Tregs were capable of suppressing autoimmune diseases (ADs). The gene discussed is CD4; the disease is colitis.